Pinnacle Wealth Planning Services, Inc. Vertex Pharmaceuticals Inc Transaction History
Pinnacle Wealth Planning Services, Inc.
- $748 Million
- Q2 2025
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 868 shares of VRTX stock, worth $354,881. This represents 0.05% of its overall portfolio holdings.
Number of Shares
868
Previous 1,086
20.07%
Holding current value
$354,881
Previous $526,000
26.62%
% of portfolio
0.05%
Previous 0.08%
Shares
20 transactions
Others Institutions Holding VRTX
# of Institutions
1,809Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.7 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.71 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.59 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.81 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...